Paris, France
Sivan provides innovative digital therapeutic for the follow up of cancer patients. Thanks to its strong scientific evidence and clinical expertise, Sivan developed Moovcare®, the first application for early detection of relapses and complications in patients with lung cancer. Moovcare® is the first digital therapeutic officially reimbursed in France.
HealthTech - BeautyTech
Technologies
Équipement médical
Applications Mobiles
Business model
B2B
Présence
France
Israël
N° Immat:
515096956
Secteurs cibles
Santé / Pharma / Médecine
Métiers cibles
Opérations - Supply chain
Partenariat(s) recherché(s)
Partenaires
JR
Marketing
Je rejoins cette équipe